Tailoring Myopic CNV Treatment Based on Preexisting Ophthalmic Condition

Invest Ophthalmol Vis Sci. 2015 Dec;56(13):8362-3. doi: 10.1167/iovs.15-18314.
No abstract available

Publication types

  • Comment

MeSH terms

  • Angiogenesis Inhibitors / therapeutic use*
  • Bevacizumab / therapeutic use*
  • Choroid / pathology*
  • Choroidal Neovascularization / drug therapy*
  • Female
  • Humans
  • Male
  • Myopia, Degenerative / drug therapy*
  • Ranibizumab / therapeutic use*
  • Vascular Endothelial Growth Factor A / antagonists & inhibitors*

Substances

  • Angiogenesis Inhibitors
  • Vascular Endothelial Growth Factor A
  • Bevacizumab
  • Ranibizumab